tiprankstipranks
Trending News
More News >

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Neutral
8Bullish
4Neutral
10Bearish
Oscillators
Sell
2Bullish
4Neutral
4Bearish
Moving Averages
Neutral
6Bullish
0Neutral
6Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is -0.40, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 17.29, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 18.12, making it a Sell.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Apr 24, 2025, 01:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.14
17.14
17.14
17.14
17.14
17.14
17.14
Fibonacci
17.14
17.14
17.14
17.14
17.14
17.14
17.14

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Apr 24, 2025, 01:36 PM
Period
Simple
Exponential
MA5
17.20Buy
17.21Buy
MA10
16.79Buy
17.07Buy
MA20
17.15Buy
17.29Buy
MA50
18.51Sell
18.12Sell
MA100
19.18Sell
18.74Sell
MA200
19.40Sell
19.08Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 17.07, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 18.74, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 18.51, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 19.18, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.40, creating a Sell signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Apr 24, 2025, 01:36 PM
Name
Value
Action
RSI (14)
51.52
Neutral
STOCH (9,6)
90.98
Sell
STOCHRSI (14)
80.78
Sell
MACD (12,26)
-0.40
Sell
ADX (14)
22.86
Neutral
Williams %R
0.15
Sell
CCI (14)
51.10
Neutral
ATR (14)
0.34
-
Ultimate Oscillator
68.90
Neutral
ROC
0.46
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 51.52, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 22.86, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 51.10, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 0.46, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Hold.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 51.52, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is -0.40, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 17.20, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 17.15, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 18.51, which suggests CURE is a Sell.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.40, which suggests CURE is a Sell.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is 0.15, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 51.10, which suggests CURE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis